Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Vaccines

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Recent Releases In Global Health

Insecticides To Fight Malaria: In a Daily Caller opinion piece, Richard Tren of Africa Fighting Malaria and Donald Roberts of the Uniformed Services University of the Health Sciences write in support of using insecticides, like DDT, to combat malaria: “Unless the donor nations that fund global malaria programs, such as the…

WHO Executive Board Supports Saving Smallpox Virus Stocks

As the WHO executive board continues meeting in Geneva this week, members “on Thursday backed efforts by the U.S. and Russia to keep the last known stocks of the smallpox virus for research to combat terrorism, in an initial debate over the fate over what is left of one of the world’s most lethal pathogens,” the Wall Street Journal reports. According to the article, the 34-member board supported the notion “that those stocks are needed to finish developing drugs and vaccines to counter a potential bioterror attack or accidental release of smallpox from unsanctioned stocks, officials familiar with the talks said.”

WHO Executive Board Meeting Addresses Agency’s Policy On Counterfeit, Substandard Medications

Intellectual Property Watch reports on how delegates at WHO’s executive board meeting used Wednesday to discuss WHO policy on counterfeit and substandard medications. According to the news service, WHO “members … raised strong concerns that a working group they mandated last May to address problems with WHO policy on counterfeit and substandard medicines has yet to be formed – with four months remaining before it must report back to members.”

Merck, Wellcome Trust Back Project To Develop Improved Rotavirus Vaccine For Developing Countries

“A joint venture between U.S. drugmaker Merck and Britain’s Wellcome Trust charity said on Monday it is working on an oral rotavirus vaccine designed to be cheaper and easier to use than current shots,” Reuters reports. “Hilleman Laboratories, an India-based joint venture set up on a not-for-profit basis in 2009, said the vaccine will aim to protect against diarrhea-causing rotavirus infections and will be based on thin strips or granules that dissolve in the mouth and can be easily transported, stored and administered.”

Mass Cholera Vaccination Early In Outbreak Could Stem Spread Of Disease, Studies Show

“The cholera bacterium has undergone important mutations in recent years, causing longer outbreaks of the disease with increased fatalities, researchers reported on Wednesday,” Reuters reports. “In a package of papers published in the journal PLoS Neglected Tropical Diseases, they said mass vaccinations should be considered as a solution even after outbreaks have begun,” the news service writes (Lyn, 1/26).

Recent Releases In Global Health

Innovative Health Financing Can Benefit Global Health, Pharma: “The launch of pneumococcal vaccination in Nicaragua under AMC [advance market commitment] has shown that innovative approaches to health financing can benefit both global health and pharmaceutical companies,” according to a Lancet Infectious Diseases editorial that describes how the roll-out of GAVI initiative…

Also In Global Health News: Medical Tourism In Southeast Asia; Cholera, Yellow Fever In Ivory Coast; U.S. Aid To Egypt; Universal Coverage In Mexico; Pneumonia’s Evolution

IRIN Examines Medical Tourism’s Affect In Southeast Asia IRIN examines how “rapid growth in medical tourism” in southeast Asian countries is affecting health systems in the region. According to the WHO, “medical tourism is leading to some highly skilled specialists, as well as other trained medical staff, leaving public health…